Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite von Nair, Pramod C., Gillani, Tina B., Rawling, Tristan, Murray, Michael

Volltext

Cytochrome P450-Mediated Biotransformation of Sorafenib and Its N‑Oxide Metabolite: Implications for Cell Viability and Human Toxicity von Gillani, Tina B, Rawling, Tristan, Murray, Michael

Volltext

Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib von Murray, Michael, Gillani, Tina B., Rawling, Tristan, Nair, Pramod C.

Volltext

Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 von Ghassabian, Sussan, Gillani, Tina B., Rawling, Tristan, Crettol, Severine, Nair, Pramod C., Murray, Michael

Volltext

Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver von Murray, Michael, Gillani, Tina B., Ghassabian, Sussan, Edwards, Robert J., Rawling, Tristan

Volltext

Anti-proliferative actions of N′-desmethylsorafenib in human breast cancer cells von Cui, Pei H., Rawling, Tristan, Gillani, Tina B., Bourget, Kirsi, Wang, Xiao-Suo, Zhou, Fanfan, Murray, Michael

Volltext